Pituitary adenoma laboratory tests: Difference between revisions
No edit summary |
No edit summary |
||
| Line 20: | Line 20: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Mature chapter]] | [[Category:Mature chapter]] | ||
Revision as of 14:52, 27 August 2015
|
Pituitary adenoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pituitary adenoma laboratory tests On the Web |
|
American Roentgen Ray Society Images of Pituitary adenoma laboratory tests |
|
Risk calculators and risk factors for Pituitary adenoma laboratory tests |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Laboratory Findings
The diagnosis is generally entertained either on the basis of visual difficulties arising from the compression of the optic nerve by the tumor, or on the basis of manifestations of excess hormone secretion: the specifics depend on the type of hormone. The specific area of the visual pathway at which compression by these tumours occurs is at the optic chiasma.
Tumors which cause visual difficulty are likely to be macroadenomata greater than 10 mm in diameter; tumors less than 10 mm are microadenomata.
Some tumors secrete more than one hormone, the most common combination being GH and prolactin.
Prolactinomas are frequently diagnosed during pregnancy, when the hormone progesterone increases the tumor's growth rate. The diagnosis is confirmed by testing hormone levels, and by radiographic imaging of the pituitary (for example, by CT scan or MRI).